Antibiotic Prophylaxis in Interventional Radiology-Anything New?

Techniques in Vascular and Interventional Radiology

Volumn 9, Issue 2, 2006, Pages 69-76

  Beddy, P ^a   Ryan, J M ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

antibiotic; interventional radiology; prophylaxis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFALEXIN; CEFAZOLIN; CEFOTIAM; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; HEPARIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ANGIOGRAPHY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BRONCHOSPASM; CHEMOEMBOLIZATION; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROJEJUNOSTOMY; GASTROSTOMY; HOSPITAL INFECTION; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; INFECTION COMPLICATION; INFECTION RISK; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVENTIONAL RADIOLOGY; ISCHEMIA; LARYNX SPASM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PERCUTANEOUS VERTEBROPLASTY; PORTOSYSTEMIC ANASTOMOSIS; PREOPERATIVE TREATMENT; RADIOFREQUENCY ABLATION; SINGLE DRUG DOSE; STENT; UTERINE ARTERY EMBOLIZATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VARICOCELE; VASCULAR ACCESS;

ANTIBIOTIC PROPHYLAXIS; HUMANS; RADIOGRAPHY, INTERVENTIONAL; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 34247553271     PISSN: 10892516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tvir.2006.12.005     Document Type: Article

References (98)

1. Spies J.B., Rosen R.J., and Lebovitz A.S. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology 166 (1988) 381-387
2. Ryan J.M., Ryan B.M., and Smith T.P. Antibiotic prophylaxis in interventional radiology. J Vasc Interv Radiol 15 (2004) 547-556
3. McDermott V.G., Schuster M.G., and Smith T.P. Antibiotic prophylaxis in vascular and interventional radiology. AJR Am J Roentgenol 169 (1997) 31-38
4. Dravid V.S., Gupta A., Zegel H.G., et al. Investigation of antibiotic prophylaxis usage for vascular and nonvascular interventional procedures. J Vasc Interv Radiol 9 (1998) 401-406
5. Darouiche R.O. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 36 (2003) 1284-1289
6. Wenzel P.R. Preoperative antibiotic prophylaxis. N Engl J Med 326 (1992) 337-339
7. Miles A.A., Miles E.M., and Burke J. The value and duration of defense reactions of the skin to primary lodgment of bacteria. Br J Exp Pathol 38 (1957) 79-96
8. Leone M., Albanese J., Tod M., et al. Ceftriaxone (1 g intravenously) penetration into abdominal tissues when administered as antibiotic prophylaxis during nephrectomy. J Chemother 15 (2003) 139-142
9. Burke J.F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50 (1961) 161-168
10. Stone H.H., Hooper C.A., Kolb L.D., et al. Antibiotic prophylaxis in gastric, biliary, and colonic surgery. Ann Surg 184 (1976) 443-452
11. Strachan C.J. Prophylactic use of cefazolin against sepsis after cholecystectomy. BMJ 1 (1977) 1254-1256
12. Classen D.C., Evans R.S., and Pestotnik S.L. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 326 (1992) 281-286
13. DiPiro J.T., Cheung R.P., Bowden T.A., et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 152 (1986) 552-559
14. Thadepalli H., and Mandal A.K. Antibiotic prophylaxis in the surgical patient. Infez Med 6 (1998) 71-80
15. National nosocomial infections surveillance (NNIS) system report. Data summary from January 1992-April 2000. Am J Infect Control 28 (2000) 429-448
16. Dzidic S., and Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 24 (2003) 519-526
17. Macpherson R.D., Willcox C., Chow C., et al. Anaesthetist's response to patients' self-reported drug allergies. Br J Anaesth 97 5 (2006) 634-639 Epub 2006
18. Cunha B.A. Antimicrobial selection in the penicillin-allergic patient. Drugs Today 37 (2001) 377-383
19. Borsch J.E., Anderson K.E., and Bindsley-Jensen C. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 98 (2006) 357-362
20. Shawker T.H., Kluge R.M., and Ayella R.J. Bacteremia associated with angiography. JAMA 229 (1974) 1180-1182
21. Meyer P., Reizine D., Aymard A., et al. Septic complications in interventional radiology: evaluation of risk and preventive measures. Preliminary studies. J Intervent Radiol 3 (1988) 73-75
22. Fiorani P., Speziale F., Calisti A., et al. Endovascular graft infection: preliminary results of an international enquiry. J Endovasc Ther 10 5 (2003) 919-927
23. Dieter R.S. Coronary artery stent infection. Clin Cardiol 23 (2000) 808-810
24. Deitch J.S., Hansen K.J., Regan J.D., et al. Infected renal artery pseudoaneurysm and mycotic aortic aneurysm after percutaneous transluminal renal artery angioplasty and stent placement in a patient with a solitary kidney. J Vasc Surg 28 (1998) 340-344
25. Deiparine M.K., Ballard J.L., Taylor F.C., et al. Endovascular stent infection. J Vasc Surg 23 (1996) 529-533
26. Bunt T.J., Gill H.K., Smith D.C., et al. Infection of a chronically implanted iliac artery stent. Ann Vasc Surg 11 (1997) 529-532
27. Kaviani A., Ouriel K., and Kashyap V.S. Infected carotid pseudoaneurysm and carotid-cutaneous fistula as a late complication of carotid artery stenting. J Vasc Surg 43 2 (2006) 379-382
28. Walton K.B., Hudenko K., D'Ayala M., et al. Aneurysmal degeneration of the superficial femoral artery following stenting: an uncommon infectious complication. Ann Vasc Surg 17 4 (2003) 445-448
29. McCready R.A., Siderys H., Pittman J.N., et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg 14 (1991) 170-174
30. Malek A.M., Higashida R.T., Reilly L.M., et al. Subclavian arteritis and pseudoaneurysm formation secondary to stent infection. Cardiovasc Intervent Radiol 23 (2000) 57-60
31. Becker G.J., Kovacs M., Mathison M.N., et al. Risk stratification and outcomes of transluminal endografting for abdominal aortic aneurysm: 7-year experience and long-term follow-up. J Vasc Interv Radiol 12 (2001) 1033-1046
32. Whitton Hollis H., and Rehring T.F. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications. J Vasc Surg 38 1 (2003) 83-87
33. Sohail M.R., Khan A.H., Holmes D.R., et al. Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80 8 (2005) 1011-1015
34. Carey D., Martin J.R., Moore C.A., et al. Complications of femoral artery closure devices. Catheter Cardiovasc Interv 52 (2001) 3-7
35. Nikolsky E., Mehren R., Halkin A., et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 15 44 6 (2004) 1200-1209
36. Openshaw K.L., Picus D., Hicks M.E., et al. Interventional radiologic placement of Hohn central venous catheters: results and complications in 100 consecutive patients. J Vasc Interv Radiol 5 (1994) 111-115
37. Richet H., Hubert B., Nitemberg G., et al. A prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 28 11 (1990) 2520-2525
38. Cicalini S., Palmieri F., and Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care 8 3 (2004) 157-162
39. Mermel L.A. New technologies to prevent intravascular catheter related bloodstream infections. Emerg Infect Dis 7 (2001) 197-199
40. Raad I., Darouiche R., Dupuis J., et al., The Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 127 4 (1997) 267-274
41. Veenstra D.L., Saint S., Saha S., et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281 3 (1999) 261-267
42. Bassetti S., Hu J., D'Agostino R.B., et al. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 45 5 (2001) 1535-1538
43. Raad I.I., and Hanna H.A. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162 8 (2002) 871-878
44. Van de Wetering D.E., and Van Woensel J.B. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2 (2003) CD003295
45. Van de W., van Woensel J.B., Kremer L.C.M., et al. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treat Rev 31 3 (2005) 186-196
46. Lin M., Soo T.B., and Horn L.C. Successful retrieval of infected Gunther Tulip IVC filter. J Vasc Interv Radiol 11 10 (2000) 1341-1343
47. Kinney T.B. Update on inferior vena cava filters. J Vasc Interv Radiol 14 4 (2003) 425-440
48. Dovrish Z., Hadary R., Blickstein D., et al. Retrospective analysis of the use of inferior vena cava filters in routine hospital practice. Postgrad Med J 82 964 (2006) 150-153
49. Miyahara T., Miyata T., Shigematsu K., et al. Clinical outcome and complications of temporary inferior vena cava filter placement. J Vasc Surg 44 3 (2006) 620-624
50. Yee A.C., and Ho C.-S. Complications of percutaneous drainage: benign versus malignant diseases. AJR Am J Roentgenol 148 (1987) 1207-1209
51. Condon R.E., and Wittmann D.H. The use of antibiotics in general surgery. In: Wills S.A. (Ed). Current Problems in Surgery (1991), Mosby Year Book, Chicago, IL
52. Hamlin J.A., Friedman M., Stein M.G., et al. Percutaneous biliary drainage: complications of 118 consecutive catheterizations. Radiology 158 (1986) 199-202
53. Funaki B., Zaleski G.X., Straus C.A., et al. Percutaneous biliary drainage in patients with nondilated intrahepatic ducts. AJR Am J Roentgenol 173 (1999) 1541-1544
54. Brody L.A., Brown K.T., Getrajdman G.I., et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol 9 (1998) 572-578
55. Thompson B.F., Arguedas M.R., and Wilcox C.M. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost?. Aliment Pharmacol Ther 16 (2002) 727-734
56. Chen C., Chen P.J., and Yang P.M. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol 92 (1997) 2257-2259
57. de Baere T., Roche A., Amenabar J.A., et al. Liver abscess formation after local treatment of liver tumors. Hepatology 23 (1996) 1436-1440
58. Kim W., Clark T.W., Baum R.A., et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 12 (2001) 965-968
59. Geschwind J.F., Kaushik S., Ramsey D.E., et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13 (2002) 1163-1166
60. Chen C., Chen P.J., Yang P.M., et al. Clinical features and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol 92 (1997) 2257-2259
61. Song S.Y., Chung J.W., Han J.K., et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 12 (2001) 313-320
62. Gauderer M.W., Ponsky J.L., and Izabt R.J. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 15 6 (1980) 872-875
63. Preshaw R.M. A percutaneous method for inserting a feeding gastrostomy tube. Surg Gynecol Obstet 152 5 (1981) 658-660
64. Giuliano A.W., Yoon H.C., Lomis N.M., et al. Fluoroscopically guided percutaneous placement of large-bore gastrostomy and gastrojejunostomy tubes: review of 109 cases. J Vasc Interv Radiol 11 2 Pt. 1 (2000) 239-246
65. Ravina J.H. Arterial embolisation to treat uterine myomata. Lancet 346 8976 (1995) 671-672
66. Pron G., Mocarski E., Cohen M., et al. Hysterectomy for complications after uterine artery embolization for leiomyoma: results of a Canadian multicenter clinical trial. J Am Assoc Gynecol Laparosc 10 (2003) 99-106
67. Walker W.J., and Pelage J.P. Uterine artery embolization in symptomatic fibroids: clinical results in 400 women with imaging follow up. Br J Obstet Gynaecol 109 (2002) 1262-1272
68. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE) (2004) Number 150, October
69. de Blok S., De Vries C., Prinssen H., et al. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 14 6 (2003) 779-783
70. Pelage J.P., Jacob D., Le Dref O., et al. Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 15 4 (2004) 405-406
71. Walker W.J., Pelage J.P., and Sutton C. Fibroid embolisation. Clin Radiol 57 (2002) 325-331
72. Ryan J.M., Gainey M., Glasson J., et al. Simplified pain protocol after uterine artery embolization. Radiology 224 (2002) 610-612
73. Siskin G.P., Stainken B.F., Dowling K., et al. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol 11 (2000) 305-311
74. Katsumori T., Nakajima K., Mihara T., et al. Uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol 178 (2002) 135-139
75. Walker W., Green A., and Sutton C. Bilateral uterine artery embolization for myomata: results, complications and failures. Min Invas Ther Allied Technol 8 (1999) 449-454
76. Pron G., Bennett J., Common A., et al., The Ontario UFE Collaborative Group. Technical results and effects of operator experience on uterine artery embolization for fibroids: The Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol 14 (2003) 545-554
77. Rajan D.K., Beecroft J.R., Clark T.W., et al. Risk of intrauterine infectious complications after uterine artery embolization. J Vasc Interv Radiol 15 12 (2004) 1415-1421
78. Vashisht A., Studd J., Carey A., et al. Fatal septicemia after fibroid embolization. Lancet 354 (1999) 307-308
79. Saxon R.R. A new era for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 15 (2004) 217-219
80. Deibert P., Schwarz S., Olschewski M., et al. Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study. Dig Dis Sci 43 (1998) 1708-1713
81. Freedman A.M., Sanyal A.J., Tisnado J., et al. Complications of transjugular intrahepatic portosystemic shunts: a comprehensive review. Radiographics 13 (1993) 1185-1210
82. Sanyal A.J., and Reddy K.R. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 115 (1998) 110-115
83. Schiano T.D., Atillasoy E., Fiel M.I., et al. Fatal fungaemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. Am J Gastroenterol 92 (1997) 709-710
84. DeSimone J.A., Beavis K.G., Eschelman D.J., et al. Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS). Clin Infect Dis 30 (2000) 384-386
85. Armstrong P.K., and MacLeod C. Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature. Clin Infect Dis 36 (2003) 407-412
86. Shibata T., Yamamoto Y., Yamamoto N., et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol 14 12 (2003) 1535-1542
87. Dupuy D.E., and Goldberg S.N. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II. J Vasc Interv Radiol 12 (2001) 1135-1148
88. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226 (2003) 441-451
89. Rhim H., Dodd G.D., Chintapalli K.N., et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24 1 (2004) 41-52
90. Alfanso O.M., Gonzalez S.A., Clemente D.J., et al. Infected vertebroplasty due to uncommon bacteria solved surgically: a rare and threatening life complication of a common procedure: report of a case and a review of the literature. Spine 31 20 (2006) E770-E773
91. Walker D.H., Mummaneni P., and Rodts G.E. Infected vertebroplasty. Report of two cases and review of the literature. Neurosurg Focus 17 6 (2004) E6
92. Mathis J.M., and Wong W. Percutaneous vertebroplasty: technical consideration. J Vasc Interv Radiol 14 (2003) 953-960
93. Goodwin W.E., Casey W.C., and Wolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. JAMA 157 (1955) 891-894
94. Gray R.R., So C.B., McLoughlin R.F., et al. Outpatient percutaneous nephrostomy. Radiology 198 (1996) 85-88
95. Cochran S.T., Barbaric Z.L., Lee J.J., et al. Nephrostomy tube placement: an outpatient procedure?. Radiology 179 (1991) 843-847
96. Millward S.F. Percutaneous nephrostomy: a practical approach. J Vasc Interv Radiol 11 (2000) 955-964
97. Beddy P., Geoghegan T., Browne R.F., et al. Testicular varicoceles. Clin Radiol 60 12 (2005) 1248-1255
98. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Guideline for Prevention of Surgical Site Infection, 1999. Am J Infect Control 27 (1999) 97-132